Third Joint Transnational Call (JTC 2016)
Basic Information
The third call of TRANSCAN-2 (JTC 2016) focuses on: “Minimally and non-invasive methods for early detection and/or progression of cancer”. Minimally invasive methods refer to techniques that have limited physical damage, burden and pain associated with the detection method, resulting in less anticipated stress, a higher screening/clinical care uptake, and more efficient and cost-effective screening and care. The studied methods should be sensitive for early detection of cancer, its staging and prediction of progression. Examples are: individual or combination of molecular, immunochemical, proteomic or genetic markers in body fluids and blood or cell samples, as well as macroscopic, microscopic and molecular imaging techniques (e.g. improved ultrasound technology, molecular imaging with contrast agents, fluorescence imaging, radiolabelling). This call excludes invasive methods, such as image-guided biopsy or surgery.
| Network | TRANSCAN-2 | ||||||||
| Website | https://www.transcanfp7.eu/calls/third-joint-transnational-call-jtc-2016.html | ||||||||
| Aim of the joint call | The third call of TRANSCAN-2 (JTC 2016) focuses on: “Minimally and non-invasive methods for early detection and/or progression of cancer”. Minimally invasive methods refer to techniques that have limited physical damage, burden and pain associated with the detection method, resulting in less anticipated stress, a higher screening/clinical care uptake, and more efficient and cost-effective screening and care. The studied methods should be sensitive for early detection of cancer, its staging and prediction of progression. Examples are: individual or combination of molecular, immunochemical, proteomic or genetic markers in body fluids and blood or cell samples, as well as macroscopic, microscopic and molecular imaging techniques (e.g. improved ultrasound technology, molecular imaging with contrast agents, fluorescence imaging, radiolabelling). This call excludes invasive methods, such as image-guided biopsy or surgery. | ||||||||
| Type of joint call | Two Stages - Call with pre-proposals and full proposals submissions | ||||||||
| Events |
|
||||||||
| Is call co-funded? | No | ||||||||
| Call follow up funding | n/a | ||||||||
| Call reasons | n/a | ||||||||
| Research fields |
|
||||||||
| Type of research | n/a | ||||||||
| Target groups |
|
||||||||
| Participating networks | n/a |
Organisations Participating
Funded Projects
| Acronym | Title | Start | End | No. partners |
|---|---|---|---|---|
| ABC-Cancer | Airborne Biomarkers for Colorectal Cancer | 4 | ||
| BioEndoCar | Biomarkers for diagnosis and prognosis of endometrial carcin... | 6 | ||
| CLEARLY | Validation of multiparametric models and Circulating and ima... | 7 | ||
| ESCEND | Detection of Early esophageal cancer by near-infrared fluore... | 3 | ||
| GLIOMA-PRD | Multiparameric Analysis of the Evolution and Progression of ... | 4 | ||
| NIRBTEST | New strategies to detect cancers in carriers of mutations in... | 5 | ||
| NOVEL | Employing NGS technology for improved, non-invasive early de... | 7 | ||
| PROLIPSY | Early Detection of Prostate Cancer by Liquid Biopsies | 5 | ||
| PROSCANEXO | Exploitation of extracellular vesicles for precision diagnos... | 5 | ||
| RESTING | Non-invasive prognostic markers for Resected Early-STage NSC... | 3 | ||
| SCRAtCH | Microbiota-based screening of anal cancer in HIV-infected in... | 5 | ||
| THRuST | Early detection of relapses in stage II-III colon cancer pat... | 6 | ||
| TRANSCALL2 | Integration of genetic biomarkers and early Minimal Residual... | 6 | ||
| iMMunocell | Single-cell immunophenotypic and transcriptomic profiling fo... | 4 |